ClinicalTrials.gov record
Completed Phase 1Phase 2 Interventional Results available

A Study to Evaluate Safety and Exploratory Efficacy of KTP-001 in Subjects With Lumbar Disc Herniation

ClinicalTrials.gov ID: NCT01978912

Public ClinicalTrials.gov record NCT01978912. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 16, 2026, 12:03 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Open-Label, Non-controlled, Single Ascending Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of KTP-001 in Subjects With Lumbar Disc Herniation

Study identification

NCT ID
NCT01978912
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
Teijin America, Inc.
Industry
Enrollment
24 participants

Conditions and interventions

Interventions

  • KTP-001 Drug

Drug

Eligibility (public fields only)

Age range
30 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2013
Primary completion
Oct 15, 2018
Completion
Oct 15, 2018
Last update posted
Feb 10, 2020

2013 – 2018

United States locations

U.S. sites
10
U.S. states
8
U.S. cities
9
Facility City State ZIP Site status
Alabama Clinical Therapeutics, LLC Birmingham Alabama 35235
HOPE Research Institute, LLC Phoenix Arizona 85018
CORE Orthopaedic Medical Center Encinitas California 92024
California Spine Diagnostic San Francisco California 94115
Compass Research, LLC Orlando Florida 32806
Emory University Atlanta Georgia 30322
Rush University Medical Center Chicago Illinois 60612
Chicago Anesthesia Pain Specialists Chicago Illinois 60657
Central Kentucky Research Associates, Inc. Lexington Kentucky 40509
William Beaumont Hospital Royal Oak Michigan 48073

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01978912, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 10, 2020 · Synced May 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01978912 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →